News

31 July, 2019

At the LIII AMVEC Congress (Mexico)

Maymó traveled to Mexico in July to attend the AMVEC Congress, the main swine congress in Mexico, to give technical support to Internacional Prode, Maymó’s exclusive distributor in Mexico.

In 2019, the LIII AMVEC Congress was held in July 23-26 in Guadalajara. Internacional Prode participated as sponsor with its own booth. Maymó was able to answer […]

30 May, 2019

Maymó launches TILKOMAY at the XXIV ANEMBE International Congress

Maymó participated as exhibitor at the XXIV ANEMBE International Congress (Spanish Buiatrics Association) that was held in Seville, Spain in May 22-24.

 

Our corporate booth focused on TILKOMAY, an innovative injectable association of tilmicosin and ketoprofen for the treatment of BRD. The launch of TILKOMAY aroused a lot of interest among the veterinarians participating in the […]

29 May, 2019

New image for all MAYMÓ products

The brand image is key to share the corporate values of a company and is necessary to spread a coherent and recognizable image to the customers, as well as to differentiate from competitors. The image of Maymó products has improved and become more modern, with some key aspects to be underlined:

 

Updated brand image.
Importance of corporate […]

20 May, 2019

The new categorisation of antimicrobials of the EMA

The deadline for public consultation of the updated new categorisation of antimicrobials ended on April 30. This new classification is an update of the recommendations published in 2014.

 

The refined classification now comprises four categories:

Category A (“Avoid”) includes antimicrobial classes not currently authorised in veterinary medicine in the EU. For these medicines, their use in food-producing […]

20 May, 2019

Approval of the second National Plan against Antibiotic Resistance (PRAN)

On March 4, the second National Plan against Antibiotic Resistance (PRAN) 2019-2021 has been approved. Health and Agricultures Ministries are involved in the PRAN, as well as the Spanish Medicine Agency (AEMPS).

 

The main activities within the new PRAN will pursue the first strategic working plan (2014-2018). The objectives are to reduce antibiotic consumption and to […]

12 April, 2019

Maymó launches TILKOMAY, an innovative association for the treatment of BRD

Tilkomay is an injectable association of tilmicosin and ketoprofen for the treatment of BRD associated with pyrexia. Tilkomay is administrated through subcutaneous route.

 

On one hand, tilmicosin has a high affinity for lung tissue. The high and long-lasting concentration in lung is responsible for its efficacy. On the other hand, this is the first time that […]